Cancer receives enduring international attention due to its extremely high morbidity and
mortality. Immunotherapy, which is generally expected to overcome the limits of traditional …

The occurrence of microorganisms has been confirmed in the tumor microenvironment
(TME) of many different organs. Microorganisms (eg, phage, virus, bacteria, fungi, and …

Genetically engineered bacteria (GEB) have shown significant promises to revolutionize
modern medicine. These engineered bacteria with unique properties such as enhanced …

This comprehensive review elucidates the profound relationship between the human
microbiome and breast cancer management. Recent findings highlight the significance of …

Superparamagnetic iron oxide nanoparticles (SPIONs) are used as contrast agents in
magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), and resulting …

Cytolethal distending toxin (CDT) is produced by a range of Gram-negative pathogenic
bacteria such as Campylobacter jejuni. CDT represents an important virulence factor that is …

The field of bacteria-based cancer therapy, which focuses on the key role played by the
prevalence of bacteria, specifically in tumors, in controlling potential targets for cancer …

Despite an overall decrease in occurrence, colorectal cancer (CRC) remains the third most
common cause of cancer deaths in the USA. Detection of CRC is difficult in high-risk groups …

To increase the antitumor drug concentration in the liver tumor site and improve the
therapeutic effects, a functionalized liposome (PPP-LIP) with tumor targetability and …

Microbial communities have evolved to colonize all ecosystems of the planet, from the deep
sea to the human gut. Microbes survive by sensing, responding, and adapting to immediate …